WO2024079664 - COMPOSITIONS AND METHODS FOR SKINCARE
National phase entry is expected:
Publication Number
WO/2024/079664
Publication Date
18.04.2024
International Application No.
PCT/IB2023/060251
International Filing Date
11.10.2023
Title **
[English]
COMPOSITIONS AND METHODS FOR SKINCARE
[French]
COMPOSITIONS ET PROCÉDÉS DE SOIN DE LA PEAU
Applicants **
AMYRIS BIO PRODUCTS PORTUGAL, UNIPESSOAL, LTDA.
UNIVERSIDADE CATÓLICA PORTUGUESA
Inventors
DIETZEL, Kevin
FERNANDES, João C.
MOREIRA, Helena Rocha
MENDES, Adelia
TARDY, Morgan
THORN LEESON, Daan
TSONG, Annie
VEIGA, Mariana
KHUSIAL, Raaj P.
Priority Data
63/415,189
11.10.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6216 | |
| EPO | Filing, Examination, Granting | 151310 | |
| Japan | Filing, Examination, Granting | 5042 | |
| South Korea | Filing, Examination, Granting | 10098 | |
| USA | Filing, Examination, Granting | 35990 |
Total:
208,656
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The disclosure provides compositions including a human milk oligosaccharide (HMO), as well as methods of using the same for reducing inflammation of the skin, treating or preventing psoriasis, acne, rosacea, eczema, erythema, UV radiation-induced inflammation, environmental pollution-induced inflammation, and/or dehydration-induced inflammation, increasing the hydration of the skin cells, improving skin barrier function, reducing fine lines or wrinkles, and/or increasing the firmness or elasticity of the skin.[French]
L'invention concerne des compositions comprenant un oligosaccharide de lait humain (HMO), ainsi que des procédés d'utilisation de celles-ci pour réduire l'inflammation de la peau, traiter ou prévenir le psoriasis, l'acné, la rosacée, l'eczéma, l'érythème, une inflammation induite par un rayonnement UV, une inflammation induite par la pollution environnementale et/ou une inflammation induite par déshydratation, augmenter l'hydratation des cellules cutanées, améliorer la fonction de barrière cutanée, réduire les ridules ou les rides, et/ou augmenter la fermeté ou l'élasticité de la peau.